127 related articles for article (PubMed ID: 34333494)
21. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
[TBL] [Abstract][Full Text] [Related]
22. Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.
Feng J; Hu M; Li Z; Hu G; Han Y; Zhang Y; Zhang M; Ren J
Cells; 2022 Aug; 11(16):. PubMed ID: 36010686
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma.
Mo C; Wu Y; Ma J; Xie L; Huang Y; Xu Y; Peng H; Chen Z; Zeng M; Mao R
BMC Med Genomics; 2022 Apr; 15(1):81. PubMed ID: 35410253
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer.
Jonsson M; Fjeldbo CS; Holm R; Stokke T; Kristensen GB; Lyng H
Neoplasia; 2019 Apr; 21(4):353-362. PubMed ID: 30856376
[TBL] [Abstract][Full Text] [Related]
26. Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods.
Gao L; Chen G; Liang ZQ; Li JD; Li DM; Tang YL; Tang D; Huang ZG; Chen JH; Luo JY; Zeng JH; Dang YW; Feng ZB
Pathol Oncol Res; 2022; 28():1610307. PubMed ID: 35693634
[No Abstract] [Full Text] [Related]
27. Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.
Esser LK; Branchi V; Shakeri F; Simon AG; Stephan C; Kristiansen G; Buness A; Schorle H; Toma MI
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35059737
[TBL] [Abstract][Full Text] [Related]
28. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
Yang Z; Cheng H; Zhang Y; Zhou Y
Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
[TBL] [Abstract][Full Text] [Related]
29. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
30. High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.
Yu K; Ji Y; Liu M; Shen F; Xiong X; Gu L; Lu T; Ye Y; Feng S; He J
Front Immunol; 2022; 13():881453. PubMed ID: 35663965
[TBL] [Abstract][Full Text] [Related]
31. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.
Chen M; Zhao Z; Wu L; Huang J; Yu P; Qian J; Ni T; Zhao C
Cell Death Dis; 2022 Sep; 13(9):784. PubMed ID: 36096885
[TBL] [Abstract][Full Text] [Related]
32. [Circular RNA CircHIPK3 Promotes NCI-H1299 and NCI-H2170 Cell Proliferation through miR-379 and its Target IGF1].
Tian F; Wang Y; Xiao Z; Zhu X
Zhongguo Fei Ai Za Zhi; 2017 Jul; 20(7):459-467. PubMed ID: 28738961
[TBL] [Abstract][Full Text] [Related]
33. Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73.
Rother K; Dengl M; Lorenz J; Tschöp K; Kirschner R; Mössner J; Engeland K
FEBS Lett; 2007 Mar; 581(6):1166-72. PubMed ID: 17336302
[TBL] [Abstract][Full Text] [Related]
34. Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells.
Lin L; Fang Z; Lin H; You H; Wang J; Su Y; Wang F; Zhang ZY
Oncol Rep; 2016 Jan; 35(1):26-32. PubMed ID: 26531156
[TBL] [Abstract][Full Text] [Related]
35. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
36. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2.
Wan Z; Wang J; Liu Q; Yang D; Li P; Wang L
Open Life Sci; 2023; 18(1):20220720. PubMed ID: 37744456
[TBL] [Abstract][Full Text] [Related]
37. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.
Tong X; Xie D; O'Kelly J; Miller CW; Muller-Tidow C; Koeffler HP
J Biol Chem; 2001 Dec; 276(50):47709-14. PubMed ID: 11598125
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
39. ACTL6A promotes the growth in non-small cell lung cancer by regulating Hippo/Yap pathway.
Ma L; Shan L
Exp Lung Res; 2021; 47(5):250-259. PubMed ID: 33896314
[No Abstract] [Full Text] [Related]
40. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
